Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Targeting selected diabetes-associated risks of atherogenesis with Bauhinia bowkeri stem bark extracts

Dissertation (MSc (Biochemistry))--University of Pretoria, 2025.

Saved in:
Bibliographic Details
Other Authors: Mosa, Rebamang A
Format: Thesis
Language:English
Published: University of Pretoria 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613479325663232
access_status_str Open Access
author2 Mosa, Rebamang A
author_browse Mosa, Rebamang A
author_facet Mosa, Rebamang A
collection Thesis
dc_rights_str_mv © 2024 University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria.
description Dissertation (MSc (Biochemistry))--University of Pretoria, 2025.
format Thesis
id oai:repository.up.ac.za:2263/103123
institution University of Pretoria (South Africa)
language English
last_indexed 2026-06-10T12:36:48.172Z
license_str Other — see source repository
provenance_str_mv Harvested via OAI-PMH from UPSpace — University of Pretoria Institutional Repository
publishDate 2025
publishDateRange 2025
publishDateSort 2025
publisher University of Pretoria
publisherStr University of Pretoria
record_format dspace
source_str UPSpace — University of Pretoria Institutional Repository
spelling oai:repository.up.ac.za:2263/103123 Targeting selected diabetes-associated risks of atherogenesis with Bauhinia bowkeri stem bark extracts Mosa, Rebamang A purityn04@gmail.com Opoku, A. R Ndlangamandla, Nomthandazo Nobuhle UCTD Sustainable development goals (SDGs) Atherogenesis Diabetes complications Hyperglycemia Cardiovascular disease (CVD) Polyol pathway Dissertation (MSc (Biochemistry))--University of Pretoria, 2025. Atherosclerosis is the main underlying cause of diabetes-associated cardiovascular disease mortalities. Persistent hyperglycemia upregulates other glucose metabolising pathways such as polyol and protein glycation pathways. These pathways contribute to the AGEs formation and ROS production. AGEs and ROS can modify key proteins, including low-density lipoprotein (LDL). LDL’s oxidative modification is the major step in atherosclerosis pathogenesis. This study searched the potential of Bauhinia bowkeri extracts (hexane, dichloromethane and methanol) to inhibit the polyol pathway and LDL modification in vitro. The in vitro aldose reductase (ALR) and sorbitol dehydrogenase (SDH) inhibition assays were used to investigate the extracts’ potential to inhibit the polyol pathway activity. Their inhibitory activity on protein glycation was investigated on LDL (and BSA) using fructose and methylglyoxal as glycating agents. The extracts’ antioxidant activity was determined using the in vitro antioxidant assays like ferric reducing power, ABTS and DPPH radical scavenging assays. Their antioxidant activity was also investigated in the copper sulphate-induced LDL peroxidation. The selected major compounds’ bioactivities were investigated using the same assays. In silico molecular docking against ALR and SDH was performed, and their ADMET properties were also studied. FTIR and GC-MS results indicated the presence of various compounds. The crude extracts showed high inhibitory activity on ALR with IC50 values ranging from 75-90.8 µg/ml, and low on SDH (IC50  185 µg/ml). The extracts also showed 59.6 - 77.8 % inhibitory activity on LDL glycation. In addition to high reducing potential, the extracts chelated Fe2+ ions and scavenged DPPH and ABTS radicals. The extracts further showed antioxidant activity on LDL oxidation with a percentage range of 13 - 74 %. While all six selected compounds showed good ADMET properties, five showed good docking scores on ALR and SDH. Monoethylhexyl phthalate showed inhibitory activity on LDL glycation and oxidation, with the highest percentage inhibitions of 43.2 % and 54.13 %, respectively. The inhibition of the polyol pathway activity, and LDL glycation and oxidation, indicates the potential of B. bowkeri extracts and their compounds to be used as therapeutic agents in the amelioration of diabetes associated macrovascular complications, like atherosclerosis. National Research Foundation (NRF) The Council for Scientific and Industrial Research (CSIR) Biochemistry, Genetics and Microbiology (BGM) MSc (Biochemistry) Unrestricted Faculty of Natural and Agricultural Sciences SDG-03: Good health and well-being 2025-07-02T13:21:09Z 2025-07-02T13:21:09Z 2025-09 2025-01 Dissertation * S2025 http://hdl.handle.net/2263/103123 https://doi.org/10.25403/UPresearchdata.29435936.v1 https://doi.org/10.25403/UPresearchdata.29435936 en © 2024 University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria. application/pdf University of Pretoria
spellingShingle UCTD
Sustainable development goals (SDGs)
Atherogenesis
Diabetes complications
Hyperglycemia
Cardiovascular disease (CVD)
Polyol pathway
Targeting selected diabetes-associated risks of atherogenesis with Bauhinia bowkeri stem bark extracts
title Targeting selected diabetes-associated risks of atherogenesis with Bauhinia bowkeri stem bark extracts
title_full Targeting selected diabetes-associated risks of atherogenesis with Bauhinia bowkeri stem bark extracts
title_fullStr Targeting selected diabetes-associated risks of atherogenesis with Bauhinia bowkeri stem bark extracts
title_full_unstemmed Targeting selected diabetes-associated risks of atherogenesis with Bauhinia bowkeri stem bark extracts
title_short Targeting selected diabetes-associated risks of atherogenesis with Bauhinia bowkeri stem bark extracts
title_sort targeting selected diabetes associated risks of atherogenesis with bauhinia bowkeri stem bark extracts
topic UCTD
Sustainable development goals (SDGs)
Atherogenesis
Diabetes complications
Hyperglycemia
Cardiovascular disease (CVD)
Polyol pathway
url http://hdl.handle.net/2263/103123
https://doi.org/10.25403/UPresearchdata.29435936.v1
https://doi.org/10.25403/UPresearchdata.29435936